… regimens for small-cell lung cancer (SCLC) and NSCLC. … Epidermal growth factor
receptor mutations can be detected … ( 5 ) Epidermal growth factor receptor mutations can be …

… , and ethnic or geographic features among lung cancer patients. We therefore evaluated …
contributions to lung cancer. Our aim was to assess the overall frequency of EGFR mutations in …

… Epidermal growth factor receptor mutations in exons 19 and 21 detected by … mutations
in non–small-cell lung cancer: (a) wild-type; (bg) 15– or 18–base pair deletion mutations…

… of the National Cancer Institute of Canada … -cell lung cancer that had failed to respond to
first- or second-line chemotherapy provides new treatment options for patients with lung cancer …

… The discovery of mutations in the tyrosine kinase domain of the epidermal growth factor
receptor (EGFR) gene in non-small cell lung cancer (NSCLC) accelerated the research of …

… cancers. This selectivity was dramatically highlighted by the finding of EGFR tyrosine kinase
domain mutations, but lung cancer … EGFR pathway in driving lung cancer pathogenesis. Of …

… growth factor receptor mutation in non-small-cell lung cancer patients … lung cancer (NSCLC)
cell lines associates with mutation and amplification of the epidermal growth factor receptor (…

… lung cancer, ~25% of lung cancer cases are not attributable to tobacco use (3). The increase
in lung cancer … in the prevalence of non-small cell lung cancer (NSCLC). NSCLC is more …

… We also obtained 93 DNA samples from non-malignant lung tissue of European-descent
patients with lung cancer in Italy and 250 DNA samples of peripheral blood mononuclear cells (…

… mutations in the epidermal growth factor receptor (EGFR) gene in non-small cell lung cancer
(NSCLC) other than the two classical mutations of L858R and exon 19 deletional mutation. …